Distinguished in Brain Tumor

Dr. Nadia N. Laack

Radiation Oncology
200 1st St Sw, 
Rochester, MN 
Accepting New Patients
Distinguished in Brain Tumor
200 1st St Sw, 
Rochester, MN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Nadia Laack is a Radiation Oncologist in Rochester, Minnesota. Dr. Laack is rated as a Distinguished provider by MediFind in the treatment of Brain Tumor. Her top areas of expertise are Ewing Sarcoma, Astrocytoma, Osteosarcoma, Glioblastoma, and Gamma Knife Radiosurgery. Dr. Laack is currently accepting new patients.

Her clinical research consists of co-authoring 195 peer reviewed articles and participating in 14 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 74 articles and participated in 3 clinical trials in the study of Brain Tumor.

Specialties
Radiation Oncology
Licenses
Radiology in WI
Hospital Affiliations
Mayo Clinic Hospital Rochester
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

MAYO CLINIC
200 1st St Sw, Rochester, MN 55905

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

A Phase 3 Randomized, Placebo-Controlled Trial Evaluating Memantine for Neurocognitive Protection in Children Undergoing Cranial Radiotherapy as Part of Treatment for Primary Central Nervous System Tumors
A Phase 3 Randomized, Placebo-Controlled Trial Evaluating Memantine for Neurocognitive Protection in Children Undergoing Cranial Radiotherapy as Part of Treatment for Primary Central Nervous System Tumors
Enrollment Status: Active_not_recruiting
Publish Date: October 14, 2025
Intervention Type: Procedure, Drug, Other
Study Drug: Memantine Hydrochloride
Study Phase: Phase 3
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Enrollment Status: Active_not_recruiting
Publish Date: October 07, 2025
Intervention Type: Drug, Procedure, Biological, Radiation
Study Drugs: Cyclophosphamide, Doxorubicin, Doxorubicin Hydrochloride, Etoposide, Etoposide Phosphate, Ganitumab, Ifosfamide, Vincristine, Vincristine Sulfate
Study Phase: Phase 3
Phase II Study of Short Course Hypofractionated Proton Beam Therapy Incorporating 18F-DOPA-PET/MRI for Elderly Patients With Newly Diagnosed Glioblastoma
Phase II Study of Short Course Hypofractionated Proton Beam Therapy Incorporating 18F-DOPA-PET/MRI for Elderly Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Completed
Publish Date: July 03, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: 18F-Fluorodopa, Temozolomide
Study Phase: Phase 2
Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study
Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study
Enrollment Status: Active_not_recruiting
Publish Date: May 18, 2025
A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
Enrollment Status: Completed
Publish Date: April 23, 2025
Intervention Type: Radiation, Drug
Study Phase: Phase 3
Evaluating the Impact of 18F-DOPA-PET on Radiotherapy Planning for Newly Diagnosed Gliomas
Evaluating the Impact of 18F-DOPA-PET on Radiotherapy Planning for Newly Diagnosed Gliomas
Enrollment Status: Completed
Publish Date: April 16, 2025
Intervention Type: Other, Procedure, Radiation, Drug
Study Drugs: Fluorine F 18 Fluorodopa, Temozolomide
Study Phase: Phase 2
Evaluating the Impact of 18F-DOPA-PET on Neurosurgical Planning for Gliomas
Evaluating the Impact of 18F-DOPA-PET on Neurosurgical Planning for Gliomas
Enrollment Status: Completed
Publish Date: January 23, 2025
Intervention Type: Procedure, Other, Drug
Study Drug: Fluorine F 18 Fluorodopa
Study Phase: Early Phase 1
A Pilot Study Evaluating the Utility of 18F-DOPA PET for Radiotherapy Treatment Planning of Malignant Glioma Patients
A Pilot Study Evaluating the Utility of 18F-DOPA PET for Radiotherapy Treatment Planning of Malignant Glioma Patients
Enrollment Status: Active_not_recruiting
Publish Date: December 31, 2024
Intervention Type: Drug
Study Drug: 18F-L-Dihydroxyphenylalanine
A Pilot Study Evaluating the Feasibility of Memantine in Reducing Cognitive Impairment in Pediatric Patients After Radiation Therapy for Central Nervous System Tumors
A Pilot Study Evaluating the Feasibility of Memantine in Reducing Cognitive Impairment in Pediatric Patients After Radiation Therapy for Central Nervous System Tumors
Enrollment Status: Completed
Publish Date: November 21, 2024
Intervention Type: Drug, Behavioral
Study Drugs: Memantine, Memantine Hydrochloride
Study Phase: Early Phase 1
Observational Study Evaluating Neurocognitive Function in Patients With Primary CNS Malignancy Receiving Radiation Treatment to the Brain
Observational Study Evaluating Neurocognitive Function in Patients With Primary CNS Malignancy Receiving Radiation Treatment to the Brain
Enrollment Status: Completed
Publish Date: May 10, 2024
A Phase II Study of Hyperfractionated Stereotactic Radiotherapy in the Treatment of Metastatic Pediatric Sarcomas of Bony Sites
A Phase II Study of Hyperfractionated Stereotactic Radiotherapy in the Treatment of Metastatic Pediatric Sarcomas of Bony Sites
Enrollment Status: Completed
Publish Date: August 27, 2020
Intervention Type: Radiation
Study Phase: Not Applicable
View 10 Less Clinical Trials

190 Total Publications

Preoperative Radiotherapy in Patients With Localized Ewing Sarcoma Enrolled on AEWS1031: A Report From the Children's Oncology Group.
Preoperative Radiotherapy in Patients With Localized Ewing Sarcoma Enrolled on AEWS1031: A Report From the Children's Oncology Group.
Journal: Pediatric blood & cancer
Published: April 02, 2025
Similar Doctors
Distinguished in Brain Tumor
Dr. Anita M. Mahajan
Radiation Oncology
Distinguished in Brain Tumor
Dr. Anita M. Mahajan
Radiation Oncology

Mayo Clinic

200 1st St Sw, 
Rochester, MN 
 (0.1 miles away)
507-284-2511
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Anita Mahajan is a Radiation Oncologist in Rochester, Minnesota. Dr. Mahajan is rated as a Distinguished provider by MediFind in the treatment of Brain Tumor. Her top areas of expertise are Brain Tumor, Glioma, Gliomatosis Cerebri, and Medulloblastoma. Dr. Mahajan is currently accepting new patients.

Distinguished in Brain Tumor
Dr. William G. Breen
Radiation Oncology
Distinguished in Brain Tumor
Dr. William G. Breen
Radiation Oncology

Mayo Clinic

200 1st St Sw, 
Rochester, MN 
 (0.1 miles away)
507-284-2512
Languages Spoken:
English
See accepted insurances
Accepting New Patients

William Breen is a Radiation Oncologist in Rochester, Minnesota. Dr. Breen is rated as an Advanced provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Brain Tumor, Glioma, Astrocytoma, Glioblastoma, and Prostatectomy. Dr. Breen is currently accepting new patients.

Distinguished in Brain Tumor
Dr. Eric J. Lehrer
Radiation Oncology
Distinguished in Brain Tumor
Dr. Eric J. Lehrer
Radiation Oncology

Mayo Clinic

200 1st St Sw, 
Rochester, MN 
 (0.1 miles away)
507-284-2511
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Eric Lehrer is a Radiation Oncologist in Rochester, Minnesota. Dr. Lehrer is rated as an Advanced provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Brain Tumor, Glioblastoma, Glioma, Tissue Biopsy, and Gamma Knife Radiosurgery. Dr. Lehrer is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Laack's expertise for a condition
ConditionClose
View All 10 Distinguished Conditions
View All 12 Advanced Conditions
View All 31 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile